Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 61.65 +2.12 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.53 | 52 Week High | $8.22 | |||
| Open | $61.75 | 52 Week Low | $3.07 | |||
| Day High | $62.00 | P/E | N/A | |||
| Day Low | $59.06 | EPS | $-1.30 | |||
| Volume | 1,615,704 | |||||
